-
Taxonomy & unit
-
ratio: %
-
Description
-
The operating margin measures the profit a company makes on a dollar of sales after accounting for the direct costs involved in earning those revenues.
-
Summary
-
BioXcel Therapeutics, Inc. quarterly/annual Operating Margin history and change rate from 2022 to Q3 2025.
- BioXcel Therapeutics, Inc. Operating Margin for the quarter ending 30 Sep 2025 was -6.74K %, a 100% decline year-over-year.
- BioXcel Therapeutics, Inc. annual Operating Margin for 2024 was -2.97K %, a 76.2% increase from 2023.
- BioXcel Therapeutics, Inc. annual Operating Margin for 2023 was -12.4K %, a 70.8% increase from 2022.
Operating Margin, Quarterly (%)
Operating Margin, YoY Quarterly Change (%)
Operating Margin, Annual (%)
Operating Margin, YoY Annual Change (%)